BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30784340)

  • 21. Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database.
    Leuzzi G; Rocco G; Ruffini E; Sperduti I; Detterbeck F; Weder W; Venuta F; Van Raemdonck D; Thomas P; Facciolo F;
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):47-57.e1. PubMed ID: 26403869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
    Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.
    Ströbel P; Bauer A; Puppe B; Kraushaar T; Krein A; Toyka K; Gold R; Semik M; Kiefer R; Nix W; Schalke B; Müller-Hermelink HK; Marx A
    J Clin Oncol; 2004 Apr; 22(8):1501-9. PubMed ID: 15084623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pencil beam scanning proton therapy for pediatric intracranial ependymoma.
    Ares C; Albertini F; Frei-Welte M; Bolsi A; Grotzer MA; Goitein G; Weber DC
    J Neurooncol; 2016 May; 128(1):137-145. PubMed ID: 26945580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymic carcinoma: outcomes after surgical resection.
    Okereke IC; Kesler KA; Freeman RK; Rieger KM; Birdas TJ; Ascioti AJ; Badve S; Nelson RP; Loehrer PJ
    Ann Thorac Surg; 2012 May; 93(5):1668-72; discussion 1672-3. PubMed ID: 22421590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
    Haefner MF; Verma V; Bougatf N; Mielke T; Tonndorf-Martini E; König L; Rwigema JM; Simone CB; Uhlmann L; Eichhorn F; Winter H; Grosch H; Haberer T; Herfarth K; Debus J; Rieken S
    Acta Oncol; 2018 Dec; 57(12):1713-1720. PubMed ID: 30264630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale and early outcomes for the management of thymoma with proton therapy.
    Zhu HJ; Hoppe BS; Flampouri S; Louis D; Pirris J; Nichols RC; Henderson RH; Mercado CE
    Transl Lung Cancer Res; 2018 Apr; 7(2):106-113. PubMed ID: 29876309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity.
    Häfner MF; Roeder F; Sterzing F; Krug D; Koerber SA; Kappes J; Hoffmann H; Slynko A; Debus J; Bischof M
    Strahlenther Onkol; 2015 Feb; 191(2):133-40. PubMed ID: 25156510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
    Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
    Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread.
    Refaely Y; Simansky DA; Paley M; Gottfried M; Yellin A
    Ann Thorac Surg; 2001 Aug; 72(2):366-70. PubMed ID: 11515868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton therapy for reirradiation of progressive or recurrent chordoma.
    McDonald MW; Linton OR; Shah MV
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.
    Macchia G; Cilla S; Deodato F; Ianiro A; Legge F; Marucci M; Cammelli S; Perrone AM; De Iaco P; Gambacorta MA; Autorino R; Valentini V; Morganti AG; Ferrandina G
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):606-13. PubMed ID: 27681755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anterior-oriented proton beams for prostate cancer: A multi-institutional experience.
    Cuaron JJ; Harris AA; Chon B; Tsai H; Larson G; Hartsell WF; Hug E; Cahlon O
    Acta Oncol; 2015 Jun; 54(6):868-74. PubMed ID: 25591937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes and Prognostic Factors After Pencil-Beam Scanning Proton Radiation Therapy for Spinal Chordomas: A Large, Single-Institution Cohort.
    Snider JW; Schneider RA; Poelma-Tap D; Stieb S; Murray FR; Placidi L; Albertini F; Lomax A; Bolsi A; Kliebsch U; Malyapa R; Weber DC
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):226-233. PubMed ID: 29619966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection.
    D'Angelillo RM; Trodella L; Ramella S; Cellini N; Balducci M; Mantini G; Cellini F; Ciresa M; Fiore M; Evoli A; Sterzi S; Russo P; Grozio A; Cesario A; Granone P
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):420-7. PubMed ID: 18164843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience.
    Yellin A; Simansky DA; Ben-Avi R; Perelman M; Zeitlin N; Refaely Y; Ben-Nun A
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):83-7; discussion 87-9. PubMed ID: 23111024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.
    Holtzman AL; Rotondo RL; Rutenberg MS; Indelicato DJ; Mercado CE; Rao D; Tavanaiepour D; Morris CG; Louis D; Flampouri S; Mendenhall WM
    J Neurooncol; 2019 May; 142(3):557-563. PubMed ID: 30827010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.